| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVIRAGEN THERAPEUTICS INC | 309,278 | 380,000 | 0.23% | ||
| 2 | CTI BIOPHARMA | 2,617,136 | 1,067,000 | 0.64% | ||
| 3 | Juniper Pharmaceuticals Inc | 228,392 | 1,279,000 | 0.76% | ||
| 4 | CUTERA INC COM | 120,429 | 2,089,000 | 1.24% | ||
| 5 | MALLINCKRODT PUB LTD CO | 43,629 | 2,174,000 | 1.29% | ||
| 6 | DURECT CORP | 2,177,791 | 2,918,000 | 1.74% | ||
| 7 | TRINITY BIOTECH PLC | 436,066 | 3,018,000 | 1.80% | ||
| 8 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 326,087 | 3,388,000 | 2.02% | ||
| 9 | CUMBERLAND PHARMACEUTICALS I COM | 619,538 | 3,407,000 | 2.03% | ||
| 10 | SUCAMPO PHARMACEUTICALS INCORPORATED CLASS A | 284,002 | 3,848,000 | 2.29% | ||
| 11 | BIODELIVERY SCIENCES INTL IN | 2,600,711 | 4,551,000 | 2.71% | ||
| 12 | ALIMERA SCIENCES INC | 4,615,813 | 4,985,000 | 2.97% | ||
| 13 | VERICEL CORP | 1,883,800 | 5,651,000 | 3.37% | ||
| 14 | VERACYTE INC | 970,500 | 7,512,000 | 4.47% | ||
| 15 | ENANTA PHARMACEUTICALS INC | 231,913 | 7,769,000 | 4.63% | ||
| 16 | CARDIOME PHARMA CORP | 3,158,816 | 8,718,000 | 5.19% | ||
| 17 | OPHTHOTECH CORP | 2,292,900 | 11,075,000 | 6.60% | ||
| 18 | NOVELION THERAPEUTICS INC | 1,524,034 | 12,832,000 | 7.64% | ||
| 19 | VIVEVE MED INC COM NEW | 2,599,711 | 13,297,000 | 7.92% | ||
| 20 | SCICLONE PHARMACEUTICALS INC | 1,249,200 | 13,491,000 | 8.04% | ||
| 21 | ALERE INC | 360,000 | 14,029,000 | 8.36% | ||
| 22 | AEGERION PHARMACEUTICALS INC | 24,200,000 | 17,243,000 | 10.27% | PRN | |
| 23 | SOCIETAL CDMO INC | 2,874,317 | 23,167,000 | 13.80% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-17-005766, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
